Eulav Asset Management Novo Nordisk A S Transaction History

Eulav Asset Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 26, 2018	SELL	$46.76 - $51.24 $3.02 Million - $3.3 Million	-64,500 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $2.17 Million - $2.47 Million	-49,000 Reduced 43.17%	64,500 $2.98 Million
Q1 2018 May 09, 2018	SELL	$48.49 - $58.14 $3.2 Million - $3.84 Million	-66,000 Reduced 36.77%	113,500 $5.59 Million
Q2 2017 Aug 14, 2017	BUY	N/A	179,500	179,500 $7.7 Million

1,881

336M

11.9M

10.6M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $199B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

Stay updated on Eulav Asset Management with notifications on news.